Blog
The Handoff Problem: Why Brilliant Science Still Stalls Before Commercial Launch
Aug 01, 2026 1,234
The ROI of Digital Twins in Bioprocess Manufacturing
Aug 01, 2026 1,309
Finding the Sweet Spot: Design Space Exploration in Biopharmaceuticals
Aug 01, 2026 2,102
Your bioprocess deserves more than basic statistics.
Aug 01, 2026 1,820
How CFD De-Risks Bioreactor Scale-Up: From Bench to 1000L
Jul 21, 2026 1,392
Fed-Batch vs. Perfusion: which process actually wins?
Aug 01, 2026 1,725
Same Quality, Lower Cost: the vendor switch playbook
Aug 01, 2026 1,762
Risk Assessment in Biopharmaceutical Development: Why It Should Never Be a One-Time Exercise
Jul 01, 2026 2,120
OOE, OOT & OOS in Biosimilar Manufacturing: A Practical Statistical Guide
Jun 01, 2026 1,840
Understanding Impact Ratio in Process Characterisation
Apr 19, 2026 1,520
Blocking in DoE for Bioprocess Development
Apr 18, 2026 1,240
Design of Experiment: Design Evaluation Guide
Jul 15, 2025 287
Scale Down Model: Equivalence Test, Benefits and Conclusion
Sep 12, 2025 398
Bioprocess Scale Down Model (SDM) vs Commercial Scale: Introduction and Goals
Mar 15, 2026 985
Process Risk Assessment: A Data-Driven FMEA Approach
Dec 10, 2025 589
Design of Experiment (DoE) for Bioprocess: An Introduction
Nov 05, 2025 523
An Introduction to Hybrid Modelling: Concept and Workflow
Oct 18, 2025 467
Cell Culture Data Analytics Flow: A Comprehensive Guide
Feb 28, 2026 756
Bioreactor Scale-Up Strategy: Key Concepts and Approaches
Jan 22, 2026 642
SDM for Bioprocess: EAC, PSD & Sample Size Calculation
Aug 25, 2025 324
Tell Us About Your Project
Our team of experienced professionals at Graphtal is ready to transform your project from idea to reality, ensuring alignment with your organisation goals through advanced data analytics and predictive modelling.
Let's simplify your work